Al-Haddad Christiane, Abdulaal Marwan, Badra Rebecca, Barikian Anita, Noureddine Bahaa, Farra Chantal
a Department of Ophthalmology , American University of Beirut Medical Center , Beirut , Lebanon , and.
b Department of Pathology and Laboratory Medicine , Medical Genetics, American University of Beirut Medical Center , Beirut , Lebanon.
Ophthalmic Genet. 2016;37(1):31-6. doi: 10.3109/13816810.2014.924015. Epub 2014 Jun 18.
The incidence of primary congenital glaucoma (PCG) varies among geographic regions and ethnic groups. The frequency of PCG in Lebanon and identification of disease-causing mutations have not been studied previously.
To investigate the role of Cytochrome P1B1 (CYP1B1) gene and Myocillin (MYOC) gene mutations in PCG in the Lebanese population and study possible genotype/phenotype correlations.
Patients with unilateral or bilateral PCG diagnosed at the American University of Beirut Medical Center and their first-degree relatives (parents and siblings) were screened for CYP1B1 and MYOC mutations. Demographic and phenotypic characteristics were recorded. Phenotypic characteristics pertaining to disease severity and outcomes were compared.
Eighteen Lebanese families (66 subjects) with at least one member affected with PCG were included in this study. Mutations in the CYP1B1 gene were detected in 6 families (33%). Five previously described mutations (p.R444Q; p.E229K; p.R469W; p.G61E; p.M1T) and one new single nucleotide deletion were identified (1793delC). Patients in whom CYP1B1 mutations were detected tended to have a more severe phenotype as evidenced by earlier age at diagnosis, higher rate of bilateral disease, and higher number of glaucoma surgeries than those in whom no CYP1B1 mutations were present. MYOC gene mutations were not detected in any patients.
The rate of CYP1B1 mutations in Lebanese patients with PCG is lower than that reported in other Arab and Middle Eastern populations and suggests other genes are responsible for PCG in the remainder.
原发性先天性青光眼(PCG)的发病率在不同地理区域和种族群体中有所不同。此前尚未对黎巴嫩的PCG发病率及致病突变进行研究。
研究细胞色素P1B1(CYP1B1)基因和肌纤蛋白(MYOC)基因突变在黎巴嫩人群PCG中的作用,并探讨可能的基因型/表型相关性。
对在美国贝鲁特美国大学医学中心诊断为单侧或双侧PCG的患者及其一级亲属(父母和兄弟姐妹)进行CYP1B1和MYOC突变筛查。记录人口统计学和表型特征。比较与疾病严重程度和预后相关的表型特征。
本研究纳入了18个黎巴嫩家庭(66名受试者),其中至少有一名成员患有PCG。在6个家庭(33%)中检测到CYP1B1基因突变。鉴定出5种先前描述的突变(p.R444Q;p.E229K;p.R469W;p.G61E;p.M1T)和1种新的单核苷酸缺失(1793delC)。与未检测到CYP1B1基因突变的患者相比,检测到CYP1B1基因突变的患者往往具有更严重的表型,表现为诊断年龄更早、双侧疾病发生率更高以及青光眼手术次数更多。在任何患者中均未检测到MYOC基因突变。
黎巴嫩PCG患者中CYP1B1基因突变率低于其他阿拉伯和中东人群报道的突变率,这表明其余患者的PCG由其他基因所致。